Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica

BACKGROUND: Human papillomavirus (HPV) infection, particularly with type 16, causes a growing fraction of oropharyngeal cancers, whose incidence is increasing, mainly in developed countries. In a double-blind controlled trial conducted to investigate vaccine efficacy (VE) of the bivalent HPV 16/18 v...

Descripción completa

Detalles Bibliográficos
Autores principales: Herrero, Rolando, Quint, Wim, Hildesheim, Allan, Gonzalez, Paula, Struijk, Linda, Katki, Hormuzd A., Porras, Carolina, Schiffman, Mark, Rodriguez, Ana Cecilia, Solomon, Diane, Jimenez, Silvia, Schiller, John T., Lowy, Douglas R., van Doorn, Leen-Jan, Wacholder, Sholom, Kreimer, Aimée R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714284/
https://www.ncbi.nlm.nih.gov/pubmed/23873171
http://dx.doi.org/10.1371/journal.pone.0068329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714284/
https://www.ncbi.nlm.nih.gov/pubmed/23873171
http://dx.doi.org/10.1371/journal.pone.0068329

Ejemplares similares